Montalban-Bravo, G., Benton, C. B., Wang, S. A., Ravandi, F., Kadia, T., Cortes, J., … Andreeff, M. (2017). More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood, 129(18), 2584–2587. https://doi.org/10.1182/blood-2016-11-749903

Montalban-Bravo, Guillermo, Christopher B. Benton, Sa A. Wang, Farhad Ravandi, Tapan Kadia, Jorge Cortes, Naval Daver, et al. “More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.” Blood 129, no. 18 (May 4, 2017): 2584–87. https://doi.org/10.1182/blood-2016-11-749903.

Montalban-Bravo G, Benton CB, Wang SA, Ravandi F, Kadia T, Cortes J, et al. More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood. 2017 May 4;129(18):2584–7.

Montalban-Bravo, Guillermo, et al. “More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.” Blood, vol. 129, no. 18, May 2017, pp. 2584–87. Pubmed, doi:10.1182/blood-2016-11-749903.

Montalban-Bravo G, Benton CB, Wang SA, Ravandi F, Kadia T, Cortes J, Daver N, Takahashi K, DiNardo C, Jabbour E, Borthakur G, Konopleva M, Pierce S, Bueso-Ramos C, Patel K, Kornblau S, Kantarjian H, Young KH, Garcia-Manero G, Andreeff M. More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood. 2017 May 4;129(18):2584–2587.